Huaxin Century Investment Group
Overview
Huaxin Century Investment Group is a Chinese private investment firm specializing in private equity, real estate, and venture capital investments. The firm focuses on early-stage to pre-IPO companies across various industries, including technology, healthcare, education, consumer goods, financial services, media, entertainment, logistics, manufacturing, energy, infrastructure, retail, automotive, agriculture, and telecommunications. Their investment strategy involves providing capital and strategic support to foster growth and innovation in these sectors. Huaxin Century Investment Group has a track record of investing in companies such as Rimag, Frontier Biotechnologies, Xueleyun, and Xuele Zhongguo, contributing to their development and expansion. The firm's approach emphasizes long-term value creation and active involvement in portfolio companies to drive sustainable success. The firm has a history of investing in various sectors, including technology, healthcare, education, consumer goods, financial services, media, entertainment, logistics, manufacturing, energy, infrastructure, retail, automotive, agriculture, and telecommunications. Their investment strategy involves providing capital and strategic support to foster growth and innovation in these sectors. Huaxin Century Investment Group has a track record of investing in companies such as Rimag, Frontier Biotechnologies, Xueleyun, and Xuele Zhongguo, contributing to their development and expansion. The firm's approach emphasizes long-term value creation and active involvement in portfolio companies to drive sustainable success. Huaxin Century Investment Group is a Chinese private investment firm specializing in private equity, real estate, and venture capital investments. The firm focuses on early-stage to pre-IPO companies across various industries, including technology, healthcare, education, consumer goods, financial services, media, entertainment, logistics, manufacturing, energy, infrastructure, retail, automotive, agriculture, and telecommunications. Their investment strategy involves providing capital and strategic support to foster growth and innovation in these sectors. Huaxin Century Investment Group has a track record of investing in companies such as Rimag, Frontier Biotechnologies, Xueleyun, and Xuele Zhongguo, contributing to their development and expansion. The firm's approach emphasizes long-term value creation and active involvement in portfolio companies to drive sustainable success.
Investment Focus
- Strong growth potential
- Innovative business models
- Experienced management teams
- Scalable operations
- Competitive market positioning
Portfolio Companies
Get the full list of 54,000+ investors
Huaxin Century Investment Group and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Huaxin Century Investment Group
What sectors does Huaxin Century Investment Group invest in?
Huaxin Century Investment Group invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Infrastructure, and is based in China. Huaxin Century Investment Group is listed as a private investment firm in the ConnectSafely investor database.
What stage does Huaxin Century Investment Group invest at?
Huaxin Century Investment Group backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.
Which regions does Huaxin Century Investment Group invest in?
Huaxin Century Investment Group invests across China.
What companies has Huaxin Century Investment Group invested in?
Huaxin Century Investment Group's portfolio includes Xueleyun, Rimag, Frontier Biotechnologies and Xuele Zhongguo.
Last updated · Source: ConnectSafely investor database


